Company Performance: NVPA.F's financial health, revenue growth, profitability, and debt levels directly influence investor confidence and stock price.

Industry Trends: The performance and outlook of the broader pharmaceutical industry, including competitor activities and market dynamics, affect NVPA.F's valuation.

Regulatory Environment: Changes in pharmaceutical regulations, drug approval processes, and pricing policies can significantly impact NVPA.F's prospects and stock price.

Economic Conditions: Overall economic health, interest rates, inflation, and global economic events can influence investor sentiment and the attractiveness of NVPA.F shares.

Market Sentiment: General market optimism or pessimism, investor risk appetite, and specific news or rumors related to NVPA.F can drive short-term price fluctuations.

Drug Pipeline: The success or failure of NVPA.F's drug development pipeline, clinical trial results, and potential for new drug approvals are major drivers of investor interest and stock price.

Mergers and Acquisitions: Potential or actual mergers, acquisitions, or partnerships involving NVPA.F can create significant price volatility.

Currency Fluctuations: As a foreign stock, currency exchange rates between the Euro and other currencies can affect the value of NVPA.F shares for international investors.

Dividend Policy: NVPA.F's dividend payouts and dividend yield can influence its attractiveness to income-seeking investors.

Management Decisions: Strategic decisions made by NVPA.F's management team, including investment strategies, research and development priorities, and cost control measures, can impact investor perceptions and stock price.